AL Amyloidosis(Amyloid Light Chain)How to Say It: am’i-loy-dō’sis
by
Cynthia M. Johnson, MA DefinitionAmyloidosis is a buildup of abnormal proteins called amyloids. The body cannot break down these proteins. Instead, they build up on tissues and organs like the heart, liver, and kidneys. This makes it hard for them to work as they should. This can be deadly. Early treatment can improve outcomes. There are several types of amyloidosis based on the protein that is involved. This fact sheet focuses on amyloidosis (AL) light chain. It is an abnormal form of antibody proteins. CausesThis problem happens when cells in the bone marrow make abnormal antibodies. These antibodies misfold, bind together, and build up on tissues and organs. Risk FactorsThis health problem is most common in people who are 50 to 70 years of age. Exposure to agent orange or certain weed killers may raise the risk of this health problem. These health problems may also be linked to AL amyloidosis:
SymptomsProblems vary from person to person. Some common ones are:
Other symptoms will depend on the organs that are affected, such as:
DiagnosisThe doctor will ask about your symptoms and health history. A physical exam will be done. Blood and urine tests will be done to look for abnormal proteins and problems with organ function. A sample of tissue or bone marrow may be taken to check for signs of the disease. This can be done with a biopsy. Other testing may include:
TreatmentThere is no cure. The goal of treatment is to manage symptoms and slow the disease. Choices are:
People who are not helped by these methods may need surgery. Deposits may be removed or an organ transplant may be needed. PreventionThere are no current guidelines to prevent this health problem. RESOURCES:Amyloidosis Foundation http://www.amyloidosis.org Genetic and Rare Diseases Information Center http://rarediseases.info.nih.gov CANADIAN RESOURCES:Canadian Organization for Rare Disorders http://www.raredisorders.ca The Kidney Foundation of Canada http://www.kidney.ca References:AL Amyloidosis. Amyloidosis Foundation website. Available at: ...(Click grey area to select URL) Accessed March 18, 2021. Amyloid light chain (AL) amyloidosis. EBSCO DynaMed website. Available at:
https://www.dynamed.com/condition/amyloid-light-chain-al-amyloidosis. Accessed March 18, 2021. Amyloidosis. National Organization for Rare Disorders website. Available at:
https://rarediseases.org/rare-diseases/amyloidosis. Accessed March 18, 2021. Wechalekar AD, Gillmore JD, et al; British Committee for Standards in Haematology Committee. Guidelines on the management of AL amyloidosis. Br J Haematol. 2015 Jan;168(2):186-206. What is amyloidosis? Boston University website. Available at: ...(Click grey area to select URL) Accessed March 18, 2021. Last reviewed December 2020 by
EBSCO Medical Review Board
Daniel A. Ostrovsky, MD Last Updated: 03/18/2021 | |
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation. This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition. To send comments or feedback to our Editorial Team regarding the content please email us at healthlibrarysupport@ebsco.com. Our Health Library Support team will respond to your email request within 2 business days. |